VAGELOS P ROY - 18 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Issuer symbol
REGN
Transactions as of
18 Aug 2021
Net transactions value
-$6,525,752
Form type
4
Filing time
19 Aug 2021, 16:05:05 UTC
Next filing
27 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -22,000 -6.3% $0.000000 327,090 27 May 2021 Direct F1
transaction REGN Common Stock Gift $0 -19,000 -5.8% $0.000000 308,090 14 Jun 2021 Direct F1
transaction REGN Common Stock Gift $0 -17,000 -5.5% $0.000000 291,090 09 Aug 2021 Direct F1
transaction REGN Common Stock Gift $0 -446 -0.31% $0.000000 142,350 01 Apr 2021 by CLAT
transaction REGN Common Stock Gift $0 -373 -0.26% $0.000000 141,977 02 Jul 2021 by CLAT
transaction REGN Common Stock Sale $6,525,752 -10,039 -21% $650.04 37,747 18 Aug 2021 by Spouse as Trustee F1, F2
holding REGN Common Stock 2,218 18 Aug 2021 By 401(k) Plan
holding REGN Common Stock 3,609 18 Aug 2021 by trust for grandch F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 10,039 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price.
F3 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.